Implantable device for wirelessly controlled drug delivery
TCCI Blog
|
Apr 8, 2022
Summary
Researchers from Stanford University have developed an implantable, ultrasound-powered drug delivery device that integrates nanoparticles and electronics for targeted, on-demand drug release. The device uses a potentiostat to control drug release by measuring the current between electrodes, and it operates wirelessly through ultrasound, making it ideal for deep tissue implantation. The system allows precise drug release, reducing side effects and improving therapeutic efficacy. Although the current limitation is drug loading capacity, ongoing research aims to enhance the device’s performance and test it with real drugs for conditions like severe diabetic hypoglycemia.
Summary
Researchers from Stanford University have developed an implantable, ultrasound-powered drug delivery device that integrates nanoparticles and electronics for targeted, on-demand drug release. The device uses a potentiostat to control drug release by measuring the current between electrodes, and it operates wirelessly through ultrasound, making it ideal for deep tissue implantation. The system allows precise drug release, reducing side effects and improving therapeutic efficacy. Although the current limitation is drug loading capacity, ongoing research aims to enhance the device’s performance and test it with real drugs for conditions like severe diabetic hypoglycemia.
